Hormone therapy HRT may shrink brain

Two new studies show that hormone therapy for women is linked to brain shrinkage, but not to the small brain lesions that are the first sign of cerebrovascular disease.

The studies are published in the January 13, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

Earlier studies showed that estrogen with or without added progestin increased the risk for developing dementia and cognitive decline, or difficulty with thinking skills and memory in women age 65 and older.

These new studies aimed to look at how the hormones might affect memory and thinking skills. The studies involved participants of the Women's Health Initiative hormone therapy clinical trials who also agreed to participate in a substudy called the Women's Health Initiative Memory Study. These studies were stopped earlier than planned when researchers found that the hormone therapy increased health risks and failed to prevent heart disease.

Researchers took MRI brain scans of 1,400 women ages 71 to 89 one to four years after the Women's Health Initiative hormone studies ended. They found women who had taken estrogen with or without progestin had smaller brain volumes in two areas of the brain than the women who had taken a placebo. Brain volume was 2.37 cubic centimeters lower in the frontal lobe in the women taking estrogen and .10 cubic centimeters lower in the hippocampus. Both areas are involved in thinking and memory skills, and loss of volume in the hippocampus is a risk factor for dementia.

"These effects were most apparent in women who may already have had some memory problems before they started taking hormones," said study author Susan Resnick, PhD, of the National Institute on Aging in Baltimore, MD. "This suggests that estrogen may adversely affect thinking skills among women whose brains may already be beginning a neurodegenerative disease process."

In the second study, researchers found that hormone therapy was not linked to an increase in volumes of small vascular lesions in the brain or "silent strokes" that are often the first sign of cerebrovascular disease. "This was not what we expected to find," said study author Laura H. Coker, PhD, of Wake Forest University Health Sciences in Winston-Salem, NC. Coker said the negative effects of hormone therapy on cognitive skills may not be related primarily to vascular disease but to neurodegeneration, which is supported by the first study's findings of brain atrophy.


(Editor compiled and published Hormone therapy HRT may shrink brain at HealthNewsTrack on January 13, 2009 sourced from American Academy of Neurology - http://www.aan.com/)

Health - recent articles and current news stories:

- Surgeons age linked to safe health care
- Poor sleep leads to health and behavior problems in young diabetics
- 30% of health spending yield no benefit to patients
- Exercise helps to eat a healthy diet and nutrition
- BPA found in soup can lining may cause adverse health effects

Health article/news source:

Read more health articles from American Academy of Neurology and health articles from USA.

Health - search related terms:

Brain, Brain lesion, Cerebrovascular disease, Cognitive, Dementia, HRT, Hormone, Hormone therapy, Memory, Neurology, Therapy,
Health books,

Subscribe to Health News by Email

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.69